Real-time enrollment status for this extranodal natural killer/t-cell lymphoma, nasal type clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:00 PM UTC
| NCT Number | NCT04288726 |
| Recruiting Status | Recruiting |
| Condition | Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type |
| Phase | Clinical Trial |
| Target Enrollment | 18 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Baylor College of Medicine |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 13, 2026: Clinical trial NCT04288726 is currently recruiting participants. This clinical trial study for extranodal natural killer/t-cell lymphoma, nasal type is actively seeking new participants at 2 locations across the United States. The study is sponsored by Baylor College of Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04288726 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04288726 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.